EDGAR Filing Documents for 0001104659-22-086733

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001104659-22-086733

Filing Date

2022-08-05

Accepted

2022-08-05 16:33:55

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	tm2222499-1_s3.htm	S-3	520280
2	EXHIBIT 1.2	tm2222499d2_ex1-2.htm	EX-1.2	246237
3	EXHIBIT 4.2	tm2222499d2_ex4-2.htm	EX-4.2	253774
4	EXHIBIT 4.3	tm2222499d2_ex4-3.htm	EX-4.3	243680
5	EXHIBIT 5.1	tm2222499d2_ex5-1.htm	EX-5.1	34964
6	EXHIBIT 5.2	tm2222499d2_ex5-2.htm	EX-5.2	5760
7	EXHIBIT 23.1	tm2222499d2_ex23-1.htm	EX-23.1	2587
8	EXHIBIT 23.2	tm2222499d2_ex23-2.htm	EX-23.2	1927
9	EX-FILING FEES	tm2222499d2_exfilingfees.htm	EX-FILING FEES	48687
10	GRAPHIC	tm2222499d2_ex5-2img001.jpg	GRAPHIC	2435
11	GRAPHIC	tm2222499d2_ex5-2img002.jpg	GRAPHIC	3869
12	GRAPHIC	tm2222499d2_ex5-1img001.jpg	GRAPHIC	2476
13	GRAPHIC	tm2222499d2_ex5-1img002.jpg	GRAPHIC	3866
14	GRAPHIC	lg_protagonist-pn.jpg	GRAPHIC	42508
	Complete submission text file	0001104659-22-086733.txt		1435864

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160

Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170

Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)